| Literature DB >> 35782869 |
Vivek Sarohi1,2, Shriya Srivastava1, Trayambak Basak1,2.
Abstract
Cardiac fibrosis-mediated heart failure (HF) is one of the major forms of end-stage cardiovascular diseases (CVDs). Cardiac fibrosis is an adaptive response of the myocardium upon any insult/injury. Excessive deposition of collagen molecules in the extracellular matrix (ECM) is the hallmark of fibrosis. This fibrotic response initially protects the myocardium from ventricular rupture. Although in mammals this fibrotic response progresses towards scar-tissue formation leading to HF, some fishes and urodeles have mastered the art of cardiac regeneration following injury-mediated fibrotic response. Zebrafish have a unique capability to regenerate the myocardium after post-amputation injury. Following post-amputation, the ECM of the zebrafish heart undergoes extensive remodeling and deposition of collagen. Being the most abundant protein of ECM, collagen plays important role in the assembly and cell-matrix interactions. However, the mechanism of ECM remodeling is not well understood. Collagen molecules undergo heavy post-translational modifications (PTMs) mainly hydroxylation of proline, lysine, and glycosylation of lysine during biosynthesis. The critical roles of these PTMs are emerging in several diseases, embryonic development, cell behavior regulation, and cell-matrix interactions. The site-specific identification of these collagen PTMs in zebrafish heart ECM is not known. As these highly modified peptides are not amenable to mass spectrometry (MS), the site-specific identification of these collagen PTMs is challenging. Here, we have implemented our in-house proteomics analytical pipeline to analyze two ECM proteomics datasets (PXD011627, PXD010092) of the zebrafish heart during regeneration (post-amputation). We report the first comprehensive site-specific collagen PTM map of zebrafish heart ECM. We have identified a total of 36 collagen chains (19 are reported for the first time here) harboring a total of 95 prolyl-3-hydroxylation, 108 hydroxylysine, 29 galactosyl-hydroxylysine, and 128 glucosylgalactosyl-hydroxylysine sites. Furthermore, we comprehensively map the three chains (COL1A1a, COL1A1b, and COL1A2) of collagen I, the most abundant protein in zebrafish heart ECM. We achieved more than 95% sequence coverage for all the three chains of collagen I. Our analysis also revealed the dynamics of prolyl-3-hydroxylation occupancy oscillations during heart regeneration at these sites. Moreover, quantitative site-specific analysis of lysine-O-glycosylation microheterogeneity during heart regeneration revealed a significant (p < 0.05) elevation of site-specific (K1017) glucosylgalactosyl-hydroxylysine on the col1a1a chain. Taken together, these site-specific PTM maps and the dynamic changes of site-specific collagen PTMs in ECM during heart regeneration will open up new avenues to decode ECM remodeling and may lay the foundation to tinker the cardiac regeneration process with new approaches.Entities:
Keywords: O-glycosylation; cardiac regeneration; collagens; extra-cellular matrix; mass-spectrometry; microheterogeneity; post-translational modifications
Year: 2022 PMID: 35782869 PMCID: PMC9245515 DOI: 10.3389/fmolb.2022.892763
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
FIGURE 1Identification of collagen chains and their relative abundances in zebrafish heart ECM: (A) Total number of collagen chains (Cabral et al., 2007) identified previously by Garcia-Puig et al. compared to (Padmanabhan Iyer et al., 2016) number of collagen chains identified in our analysis. (B) depicts inclusion of hydroxyproline (HyP) modification in the database search by MyriMatch and MSFragger resulting in identification of almost 61.12 and 40.46% (summed number from all the raw *.pepXML files used for database search) new unique peptides. This strategy yielded more no. of peptide identification resulting in a higher number of collagen chain identification from the same dataset. (C) Top 10 abundant collagen chains deposited in the zebrafish heart ECM were identified by two different search engines MyriMatch and MSFragger respectively. (D) Relative abundances of different collagen chains during zebrafish heart regeneration are shown by the heatmap. Light yellow represents the lower value (−2) and dark red represents the higher value (+2) in the row. Normalized spectral count values have been used to generate the heatmap (considering ≥ 3 spectral counts per chain). collagen chains marked with red (.) dots are quantitated during regeneration in re-analysis for the first time (DPA = day post amputation).
FIGURE 2Optimized dual database search engine-based MS analysis pipeline for the global identification and quantitation of site-specific collagen PTMs from zebrafish heart ECM. Thermo. raw or Bruker. d MS/MS files were initially converted to. mgf and. mzML files (by MSConvert) respectively and searched with MyriMatch and MSFragger to identify the collagen present in the zebrafish heart ECM. For MyriMatch, the subset of identified proteins was used as a second database to perform a PTM module enabled search defining specific sequence motifs for the site-specific identification of collagen PTMs in zebrafish heart ECM. For MSFragger, the PTM searches were conducted directly with the entire zebrafish database. From MyriMatch and MSFragger *.pep.XML output files containing each peptide spectrum match (PSM) were further parsed by PeptideProphet to compute the probability score (0,1). The *.pep.XML output file parsed by PeptideProphet was further imported into Skyline along with all the raw MS/MS files in to generate the spectral library (.blib). This spectral library (.blib) in Skyline was used for the targeted MS1-based extraction of all the PTM modified and unmodified collagen peptide species for each specific site. The area of MS1 area for each peptide for different samples was computed from Skyline.
Mass-Spectrometry-based identification of site-specific hydroxylation and glycosylation of different collagens present in the zebrafish cardiac ECM.
| Collagen chains | 3-Hydroxyproline Sites (95) | Hydroxylysine Sites (108) | Galactosyl-Hydroxylysine Sites (29) | Glucosylgalactosyl-Hydroxylysine Sites (128) |
|---|---|---|---|---|
| COL1A1a | P176, P188, P317, P401, P443, P446, P551, P623, P707, P755, P800, P854, P869, P878, P881, P911, P980, P992, P1034, P1103, P1106, P1148, P1166, P1169 | K261, K270, K336, K381, K414, K426, K432, K504, K522, K570, K596, K641, K693, K726, K735, K765, K810, K819, K846, K918, K1017, K1080, K1191 | K261, K270, K432, K504, K570, K693, K819, K846, K1191 | K261, K270, K432, K504, K522, K570, K693, K726, K819, K846, K1017 |
| COL1A1b | P176, P191, P302, P320, P404, P470, P554, P758, P872, P881, P914, P938, P983, P1031, P1109, P1151, P1175 | K215, K264, K273, K339, K384, K417, K429, K525, K573, K618, K696, K738, K746, K768, K813, K849, K900, K1020, K1193 | K264, K273, K849, K1020 | K264, K273, K339, K849 |
| COL1A2 | P56, P59, P244, P286, P361, P451, P469, P673, P718, P787, P820, P838, P925, P1066, P1081 | K74, K179, K188, K254, K299, K344, K350, K454, K488, K500, K533, K578, K644, K647, K683, K731, K737, K836, K935, K998, K1004 | K74, K188, K254, K344, K350, K644 | K74, K167, K188, K254, K299, K578, K644, K647, K935 |
| COL4A1 | P201, P204, P294, P297, p1338 | K463, K466, K882, K909, K1149, K1179, K1182 | ||
| COL5A1 | P686, P746, P824, P1112, P1115, P1163, P1166, P1190, P1193, P1253, P1421, P1424 | K1134, K1296, K1329, K1497 , K1578, K1581, K1592, K1604, K1644 | K1344 | K623, K626, K753, K813, K945, K1104, K1209, K1245, K1290, K1338, K1383, K1455 , K1482 , K1578, K1581 |
| COL5A2a | P241, P277, P532, P661, P868, P901, P937, P967, P1105 | K280, K329, K449, K482, K494, K709, K749, K803, K878, K986, K1036, K1078, K1124, K1135 | K329, K338, K500, K557, K572, K761, K761, K794, K638, K803, K887 | |
| COL6A1 | P574, P577 | K482, K538 | K398, K488, K538, K560, K563 | |
| COL6A3 | K1796, K1975 | K1660, K1778, K1796, K1711, K1963, K1880, K1889 | ||
| COL6A2 | P470 | K387 | K539 | K339, K387, K426, K435, K438, K456, K459, K539, K545 |
| COL11A1a | P919 | K1313 | K1217, K1304 | K911, K1148, K1151 |
| COL4A2 | P339, P555, P613 | K593, K704, K707, K1620, K1651 | K689 | K54, K72, K318, K567, K582, K593, K662, K674, K689, K704, K707, K725, K948, K951, K969, K1045, K1048, K1076, K1235, K1247, K1283, K1292, K1331, K1346 |
| COL4A5 | P93 | K127, K214 | K225 | K225 |
| COL6A4a | - | - | K1501 | K1490, K1787, K1796, K2148 |
| COL2A1a | - | K612 | K423 | K423, K1178 |
| COL2A1b | ||||
| COL16A1 | - | K1008, K1343, K1495, K1498 | - | K644, K654, K1008, K1233 |
| COL11A1b | - | - | - | K1191, K1400 |
| COL5A2b | P838 | - | - | K731 |
| COL11A2 | P1133 | K959, K963 | - | K1188, K1197, K1200, K1203 |
| COL7A1 | - | - | - | K1504, K2136 |
| COL5A3b | P437, P467 | - | - | - |
| COL22A1 | - | K495, K1128 | K788, K1538 | K498, K513, K785 |
| COL17A1a | P1156 | - | - | - |
FIGURE 3Comprehensive map of proline/lysine hydroxylation sites and lysine O-glycosylation sites in COL1A1a of WT zebrafish heart ECM. Identified peptide sequence in the proteomic analysis is shown in black color, sequence not identified in this analysis are shown in grey color. A total of 94.98% sequence coverage of COL1A1a is detected (considering the matured form of COL1A1The signalgnal peptide is 22 amino acids (1–22) long. Sequence alignment matching with human COL1A1 revealed the propeptide cleavage sites. Dark yellow arrows show N terminal (23–146) and C-Term (1,202–1,447) propeptide cleavage sites. As shown in the top right corner, red bold “P” with a blue star represents 3-hydroxyproline on the Xaa position followed by 4-hydroxyproline the on Yaa position in the Gly-Xaa-Yaa motif. 4-hydroxyproline on Yaa position is represented with red color “P”. Hydroxyproline on unusual Xaa position with (Ala, Val, Met, Ile, Ser, Glu, Arg, and Asp) on Yaa position are also identified but cannot label either 3-hydroxyproline or 4-hydroxyproline. Hydroxylysine sites are presented by bold “K”. Lysine sites highlighted with a yellow circle represents galactosyl-hydroxylysine sites and yellow plus blue coloued circles represent glucosylgalactosyl-hydroxylysine sites. The presence of glucosylgalactosyl-hydroxylysine, galactosyl-hydroxylysine, and hydroxylysine on the same site shows lysine microheterogeneity. A summary of these site-specific PTMs of COL1A1a is presented in Table 1, and all the PSMs for O-glycosylated lysine and 3-hydroxyproline sites are provided in Supplementary Figure S2.1-S2.21.
FIGURE 4Comparison of 3-HyP sites identified in COL1A1a from zebrafish heart ECM to COL1A1 of human and mice heart ECM. The horizontal box represents the full-length COL1A1 sequence and the vertical black lines indicate the corresponding 3-HyP sites. The information for 3-HyP sites of human and mice heart ECM were re-analyzed in this manuscript from the available raw MS data from Barallobre-Barreiro et al. and Padmanabhan et al. The 3-HyP sites marked with red represent the conserved sites among human, mouse, and zebrafish.
FIGURE 5Comprehensive PTM map of COL1A1b of WT zebrafish heart ECM, presenting proline/lysine hydroxylation sites and lysine O-glycosylation sites. The representation of PTM sthe ites is similar to the COL1A1a PTM map as shown in top right corner. Peptides identified in proteomics analysis are shown in black color and unidentified peptides are shown in grey color. A total of 96.48% sequence coverage of COL1A1a is detected (considering the matured form of COL1A1b). The signal peptide is 22 amino acids (1–22) long. Sequence alignment matching and previous analysis by Gistelink et al. with human COL1A1 revealed the propeptide cleavage sites. Dark yellow arrows show N terminal (23–150) and C-Term (1,204–1,447) propeptide cleavage sites. Red bold “P” with a blue star represents 3-HyP and red “P” represents 4-HyP. Hydroxylysine is represented with bold “K” and yellow and blue circle represents the lysine O-glycosylation. A summary of these site-specific PTMs of COL1A1b is presented in Table 1, and all the PSMs for O-glycosylated lysine and 3-hydroxyproline sites are provided in Supplementary Figures. S2.22–S2.52.
FIGURE 6Comprehensive map of COL1A2 of ECM of WT zebrafish heart. It presents proline/lysine hydroxylation sites and lysine glycosylation sites. Representation of PTM sites is similar to COL1A1a and COL1A1b PTM maps. Peptides identified in proteomics analysis are shown in black color and unidentified peptides are shown in grey color. Total 97.21% sequence coverage of COL1A2 is detected (considering the matured form of COL1A1b). The signal peptide is 22 amino acids (1–22) long. N terminal propeptide (23–68) and C terminal propeptide (1,109–1,352) cleavage sites are marked with dark yellow arrows. Red bold “P” with blue star represents 3-HyP and red “P” represents 4-HyP. Hydroxylysine is represented with bold “K” and yellow and blue circle represents the lysine O-glycosylation. A summary of these site-specific PTMs of COL1A2 is presented in Table 1, and all the PSMs for O-glycosylated lysine and 3-hydroxyproline sites are provided in Supplementary Figure S2.53–S2.83.
Quantitative occupancy (%) of 3-hydroxyproline (3-HyP) sites identified in three different chains of collagen I (COL1A1a, COL1A1b, and COL1A2) from zebrafish cardiac ECM. Results are expressed as mean ± S.D. Significant statistical differences were estimated by ANOVA (*p < 0.05, nsp > 0.05).
| 3-HyP site | 3-Hydroxyproline average occupancy % | |||
|---|---|---|---|---|
| Sham average | 7 DPA Average | 14 DPA Average | 30 DPA Average | |
| COL1A1a P707 | 7.55 ± 4.3 | 31.49 ± 38.1 | 21.21 ± 7.8 | 20.50 ± 1.5 ns |
| COL1A1a P869 | 35.37 ± 6.9 | 22.82 ± 13.3 | 48.10 ± 63.8 | 20.12 ± 2.9 ns |
| COL1A1a P878 | 28.87 ± 7.2 | 17.57 ± 18.4 | 27.63 ± 35.8 | 12.76 ± 1.8 ns |
| COL1A1a P1148 | 48.73 ± 14.7 | 44.03 ± 17.0 | 68.96 ± 41.1 | 7.23 ± 4.6ns |
| COL5A2a P1195, 1201 | 1.77 ± 1.3 | 23.97 ± 4.5 | 55.24 ± 47.4 | 30.04 ± 41.1 ns |
| COL1A2 P718 | 0.19 ± 0.1 | 0.20 ± 0.3 | 0.10 ± 0.1 | 10.54 ± 7.4 ns |
| COL1A2 P925 | 5.14 ± 5.7 | 10.00 ± 13.2 | 0.53 ± 0.7 | 1.86 ± 1.8 ns |
| COL1A2 P1066 | 3.92 ± 3.4 | 3.87 ± 3.1 | 12.95 ± 15.7 | 6.91 ± 2.0 ns |
| COL1A2 P361 | 0.96 ± 0.3 | 1.52 ± 1.6 | 4.66 ± 4.5 | 1.18 ± 0.4 ns |
| COL1A1b P404 | 7.88 ± 1.9 | 18.28 ± 12.8 | 30.08 ± 6.7 | 11.95 ± 7.1 ns |
| COL1A1b P554 | 47.73 ± 4.0 | 46.52 ± 14.8 | 76.14 ± 29.7 | 42.91 ± 1.3 ns |
| COL1A1b P914 | 17.09 ± 1.4 | 16.74 ± 10.6 | 21.16 ± 14.0 | 47.35 ± 6.2 ns |
| COL1A1b P1031 | 12.44 ± 16.1 | 32.42 ± 34.0 | 18.31 ± 24.2 | 33.45 ± 3.6 ns |
| COL1A1b P1109 | 10.36 ± 7.6 | 3.93 ± 1.7 | 4.76 ± 6.0 | 32.64 ± 18.6 ns |
FIGURE 7Heatmap depicting the relative occupancy level of 3-hydroxyproline sites in three different chains of collagen 1 deposited in zebrafish heart ECM during regeneration. Further occupancy of one 3-HyP cluster of COL5A2a1195, 1201 was also quantitated during zebrafish heart regeneration. Normalized occupancy values of prolyl-3-hydroxylations were computed to generate the heat map. Light yellow represents the low value (lowest occupancy) and dark red shows the higher value (highest occupancy) in the row.
Quantitative micro-heterogenic occupancy (%) of O-glycosylated lysine sites identified three different chains of collagen I (COL1A1a, COL1A1b, and COL1A2) from zebrafish cardiac ECM. Results are expressed as mean ± SEM. Statistically significant differences were estimated by ANOVA (*p < 0.05, ns > 0.05). N/D, not detected; HyK, hydroxylysine; G-HyK, galactosyl-hydroxylysine; GG-HyK, glucosylgalactosylhydroxylysine.
| Microheterogeneity % | |||||
|---|---|---|---|---|---|
| Lysine sites | Modification | Sham | 7 DPA | 14 DPA | 30 DPA |
| COL1A1a K261 | K | 36.62 ± 9.7 | 43.75 ± 4.38 | 46.09 ± 4.89 | 32.30 ± 5.08 ns |
| HyK | 38.38 ± 10.38 | 34.81 ± 12.3 | 21.13 ± 2.85 | 45.72 ± 8.65 ns | |
| G-HyK | 16.71 ± 4.9 | 17.85 ± 12.0 | 31.26 ± 3.01 | 20.22 ± 3.01 ns | |
| GG-HyK | 8.28 ± 6.5 | 3.59 ± 4.3 | 1.32 ± 0.97 | 2.35 ± 0.57 ns | |
| COL1A1a K270 | K | 50.46 ± 5.3 | 32.92 ± 4.4 | 26.58 ± 1.7 | 46.48 ± 4.1 ns |
| HyK | 34.97 ± 0.7 | 37.13 ± 1.3 | 46.12 ± 1.1 | 40.69 ± 4.4 ns | |
| G-HyK | 12.26 ± 5.0 | 29.03 ± 4.4 | 24.56 ± 2.7 | 11.52 ± 0.4 ns | |
| GG-HyK | 2.32 ± 1.1 | 0.93 ± 1.3 | 2.74 ± 0.2 | 1.30 ± 0.7 ns | |
| COL1A1a K504 | K | 35.12 ± 0.2 | 6.54 ± 0.3 | 34.96 ± 46.9 | 51.61 ± 20.2 ns |
| HyK | 7.20 ± 4.4 | 3.49 ± 0.3 | 16.03 ± 22.4 | 16.85 ± 5.2 ns | |
| G-HyK | 57.68 ± 4.2 | 89.97 ± 0.0 | 49.01 ± 69.3 | 31.54 ± 15.0 ns | |
| GG-HyK | ND | ND | ND | ND | |
| COL1A1a K570 | K | 59.52 ± 12.5 | 24.79 ± 15.4 | 17.67 ± 1.6 | 42.84 ± 51.5 ns |
| HyK | 14.06 ± 4.6 | 6.83 ± 7.6 | 4.50 ± 0.1 | 0.21 ± 0.3 ns | |
| G-HyK | ND | ND | ND | ND | |
| GG-HyK | 26.42 ± 17.1 | 68.39 ± 7.8 | 77.83 ± 1.6 | 56.95 ± 51.8 ns | |
| COL1A1a K693 | K | 16.05 ± 1.8 | 11.35 ± 1.4 | 21.14 ± 15.4 | 17.46 ± 2.3 ns |
| HyK | 73.86 ± 2.2 | 83.40 ± 0.1 | 70.60 ± 23.8 | 74.25 ± 1.7 ns | |
| GK | 1.34 ± 0.3 | 0.25 ± 0.4 | 0.56 ± 0.8 | 1.47 ± 0.2 ns | |
| GGK | 8.75 ± 0.4 | 5.00 ± 1.0 | 7.69 ± 9.2 | 6.82 ± 3.8 ns | |
| COL1A1a K846 | K | ND | ND | ND | ND |
| HyK | ND | ND | ND | ND | |
| G-HyK | 48.69 ± 29.7 | 85.04 ± 19.4 | 51.02 ± 9.0 | 68.87 ± 5.5 ns | |
| GG-HyK | 51.31 ± 29.7 | 14.96 ± 19.4 | 48.98 ± 9.0 | 31.13 ± 5.5 ns | |
| COL1A1a K1017 | K | 62.44 ± 0.3 | 33.69 ± 22.8 | 52.55 ± 21.8 | 60.09 ± 0.5 ns |
| HyK | 34.82 ± 0.4 | 62.96 ± 20.9 | 36.95 ± 22.1 | 24.44 ± 0.2 ns | |
| G-HyK | ND | ND | ND | ND | |
| GG-HyK | 2.74 ± 0.7 | 3.35 ± 1.9 | 10.50 ± 0.3 | 15.47 ± 0.3 * | |
| COL1A1b K264 | K | 50.52 ± 15.5 | 40.63 ± 50.7 | 52.94 ± 15.8 | 20.39 ± 20.2 ns |
| HyK | 41.23 ± 8.2 | 53.16 ± 56.0 | 30.76 ± 34.6 | 46.65 ± 44.7 ns | |
| G-HyK | 5.19 ± 4.4 | 4.64 ± 3.6 | 9.75 ± 10.8 | 27.51 ± 20.7 ns | |
| GG-HyK | 3.05 ± 2.9 | 1.57 ± 1.6 | 6.54 ± 7.9 | 5.45 ± 3.7 ns | |
| COL1A1b K273 | K | ND | ND | ND | ND |
| HyK | 41.65 ± 47.5 | 50.93 ± 39.7 | 24.43 ± 25.6 | 33.90 ± 36.0 ns | |
| G-HyK | 5.58 ± 4.6 | 33.38 ± 20.8 | 27.55 ± 13.3 | 19.99 ± 10.5 ns | |
| GG-HyK | 52.77 ± 42.9 | 15.69 ± 19.0 | 48.02 ± 38.9 | 46.11 ± 25.5 ns | |
| COL1A1b K849 | K | 27.06 ± 1.1 | 10.35 ± 13.7 | 11.17 ± 2.2 | 22.95 ± 3.4 ns |
| HyK | 67.46 ± 1.1 | 68.53 ± 16.8 | 70.77 ± 9.7 | 62.89 ± 0.3 ns | |
| G-HyK | 3.35 ± 0.4 | 6.76 ± 9.4 | 12.97 ± 4.5 | 9.48 ± 1.5 ns | |
| GG-HyK | 2.13 ± 0.4 | 14.36 ± 12.4 | 5.09 ± 2.9 | 4.68 ± 2.2 ns | |
| COL1A2 K254 | K | 6.48 ± 3.2 | 20.75 ± 14.6 | 21.61 ± 14.3 | 55.69 ± 18.4 ns |
| HyK | 89.24 ± 1.6 | 78.24 ± 13.4 | 69.76 ± 2.2 | 43.90 ± 18.1 ns | |
| G-HyK | 0.11 ± 0.0 | 0.10 ± 0.1 | 0.22 ± 0.3 | 0.05 ± 0.0 ns | |
| GG-HyK | 4.17 ± 4.8 | 0.91 ± 1.1 | 8.40 ± 11.7 | 0.36 ± 0.3 ns | |
| COL1A2 K644 | K | ND | ND | ND | ND |
| HyK | 84.59 ± 1.8 | 61.15 ± 40.2 | 95.15 ± 6.5 | 90.77 ± 11.1 ns | |
| G-HyK | ND | ND | ND | ND | |
| GGK | 15.41 ± 1.8 | 38.85 ± 40.2 | 4.85 ± 6.5 | 9.23 ± 11.1 ns | |
FIGURE 8Quantitation of microheterogeneity of K1017 site in COL1A1a present in zebrafish heart ECM during regeneration. (A) Chromatogram plots represent the elution of unmodified (K), hydroxylysine (HyK), and glucosylgalactosyl-hydroxylysine (GG-HyK) modified K1017 site containing peptide 1011DGAAGPKGDRGETGPSGTPGAPGPPGAAGPIGPAGK1046 (B) Graphical representation of Skyline-based MS1 quantitation of micro-heterogenic distribution of unmodified K1017 (yellow), HyK1017 (green) and GG-HyK277 (blue) species in COL1A1a from the ECM digest of control, 7 DPA, 14 DPA, and 30 DPA regenerating zebrafish heart. The different colors in the bar represent the occupancy of different forms at the K1017 site in COL1A1a with mean ± SEM. An increase in glucosylgalactosyl-hydroxylysine levels during regeneration is significant (ANOVA, p < 0.05) (See Table 3)